Cannabis Law Report

JUNE 7, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Department of Agriculture (USDA) or equivalent foreign regulatory agencies to conduct clinical trials and whether and when, if at all, they will receive final or conditional approval from the U.S.

Clinical Trials

Cannabis Law Report

NOVEMBER 9, 2021

As an institution dedicated to diagnosing and treating serious blood diseases and with the ability to pursue investigational medicines from development to manufacture and clinical trial for patients who have exhausted all approved treatment options, having a cost-effective and rapid production chain is integral to ÚHKT’s mission.

Clinical Trials

Cannabis Law Report

MARCH 25, 2020

(OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM ® Biotechnologies, Inc.

Research and Development

SpeedWeed

AUGUST 4, 2021

For the past four years, I have worked full-time in the cannabis industry, learning everything I can about every aspect of the cultivation and supply chain to determine where MCA can add value to the industry. Describe MCA and the mission of the company. Where do you see your firm in the next 10 years?

Chronic Pain

Cannabis Law Report

JANUARY 24, 2022

The CBD segment dominated the market in 2021 due to the growing awareness about the positive effects of CBD for the treatment of various medical conditions, such as chronic pain, cancer & multiple sclerosis. North America Legal Cannabis Number of clinical trials. In 2021, the recreational segment dominated the market.

Legalization

Cannabis Law Report

NOVEMBER 15, 2021

The LinearDNA platform also has non-biologic applications, such as supply chain security, anti-counterfeiting and anti-theft technology. Applied DNA has also established a COVID-19 diagnostic and testing offering that is grounded in the Company’s deep expertise in DNA. Visit adnas.com for more information.

Research and Development

Cannabis Law Report

JULY 15, 2022

Federal Member for Fairfax Ted O’Brien said strict controls of the supply chain would be critical to the Government’s aspirations to make Australia the number one world player in medicinal cannabis. Different strains for different conditions. Different strains are grown to treat different medical conditions.

Medicine

Cannabis Law Report

NOVEMBER 7, 2019

chemovars) in house to ensure strict guidelines are followed to supply a consistent and clean medicinal product at low costs. With a strong focus on research and development ranging from agronomic research through to clinical trials Cannatrek has an extensive R&D portfolio from Seed to Patient.

Medicine

The Cannigma

MAY 7, 2021

It was a lot more lenient for cannabis producers to supply patients all across North America for the last 15 years and I think, it’s not only the mindset but it’s the supply chain makeup that is quite different in terms of how the market is being supplied on both sides of the Atlantic.

Supply Chain

Veriheal

AUGUST 31, 2020

However, social and economic barriers like racial stereotypes and lack of access to care centers have historically barred Hispanic community members from seeking medical cannabis and participating in clinical trials. Supply chains are disrupted as a result, and consumers grow fearful of buying hemp.

Research and Development

Cannabis Law Report

AUGUST 30, 2019

Iowa’s Medical Cannabidiol Board formally approved a measure to add chronic pain to the list of conditions that qualify a patient for medical cannabis. The measure was the first expansion of Iowa’s medical cannabis program since Governor Kim Reynolds (R) vetoed a proposed expansion earlier this year. Medical/Health.

Banking